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Microarray and bioinformatics analyses
Microarray analysis and gene expression proﬁ  ling allow 
patterns of gene expression in diseases and develop-
mental processes to be assessed. Advances in biological 
databases have enabled the large-scale expression proﬁ  l-
ing data to be processed and the foundation for biological 
interpretation to be laid. Despite this, a major limitation 
involves the interpretation of massive amounts of micro-
array data. In microarray analysis, which is often used to 
identify diﬀ   erentially expressed genes, genes that are 
expressed at higher or lower levels than controls are of 
interest. In the previous issue of Arthritis Research & 
Th  erapy, Lee and colleagues [1] conducted gene expres-
sion and bioinformatics analyses between healthy 
individuals and patients with systemic lupus erythema-
tosus (SLE) and provided insights into biological and 
functional abnormalities in SLE as well as abnormal 
regulatory networks. Such analyses – that is, gene 
ontology analysis, which is used to classify genes into 
functionally related gene groups, and network pathway 
analysis, which identiﬁ   es relationships among these 
genes – provide an additional layer of insight that cannot 
be achieved by focusing on individual molecules [1].
Interferon signature
Lee and colleagues [2] previously demonstrated, by DNA 
microarray and bioinformatics analyses, that genes related 
to the immune response were diﬀ  erentially expressed in 
patients with SLE compared with healthy controls. Other 
studies have also reported increased expres  sion of IFN-
inducible genes (that is, the ‘IFN signature’) in peripheral 
blood cells from patients with SLE [2-4]. Many groups are 
currently looking into patho  logical roles of plasmacytoid 
dendritic cells (pDCs) and IFN-inducible genes in SLE 
since pDCs are major producers of IFN-α [4-7]. Given 
that SLE is a systemic disease that inﬂ  uences multiple 
organs, Lee and colleagues [1] emphasized the importance 
of assessing biological and cellular abnormalities 
associated with SLE other than those related to the 
immune response. To this end, the authors revealed not 
only that apoptosis-related genes are up  regulated but also 
that genes related to sensory perception and response to 
radiation/light were down  regulated.
Abnormalities in DNA repair and ATP synthesis
Downregulated genes associated with sensory perception 
and response to radiation/light included ATPase/ATPase 
domain-containing genes, two excision repair cross-
complementing genes (ERCC2 and ERCC5), and six 
mito  chon  drial DNA (mtDNA) encoded genes: ATP 
synthase 6 (ATP6), cytochrome c oxidases 1 (COX1) and 
3 (COX3), cytochrome b (CYTB), and NADH dehydro-
genase sub  units 1 (ND1) and 2 (ND2). ERCC2/XPD and 
ERCC5/XPG are both involved in excision repair of UV-
induced DNA damage. Patients with Xeroderma pigmen-
tosum, Cockayne syndrome, or trichothiodystrophy 
harbor mutations in ERCC genes, and such patients 
exhibit photo  sensitivity. Th  e process of UV-induced 
DNA damage repair is known to require ATP, and the 
main function of mitochondria is to generate ATP 
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regulation of ATP-dependent ERCC genes and mtDNA-
encoded genes implies that impaired DNA repair and 
ATP synthesis, or increased apoptosis, may contribute to 
the various manifestations of SLE. Consistent with this, a 
study by Fernandez and Perl [8] showed that mito  chon-
drial hyperpolarization and ATP depletion predispose 
lupus T cells to necrosis. Via network pathway analysis, 
Lee and colleagues [1] demon  strated that cytokines IL-6, 
transforming growth factor-beta (TGF-β), and TNF play 
central roles as ATP synthesis-related molecules. Patients 
with SLE had signiﬁ  cantly higher levels of TNF and IL-6, 
which are proinﬂ  ammatory, whereas levels of the anti-
inﬂ  ammatory cytokine TGF-β were lower [9]. Further-
more, Pﬂ  egerl and colleagues [10] reported that epider-
mal loss of Jun B, which is linked to increased epidermal 
IL-6 secretion, is suﬃ   cient to induce an SLE phenotype 
in mice, and this suggests that defects in skin function 
may lead to systemic autoimmune diseases.
Conclusions
Lee and colleagues [1] revealed func  tional abnormalities 
in ATP synthesis and DNA repair in peripheral blood 
cells from patients with SLE. Further DNA microarray 
and bioinformatics analyses should provide interesting 
insights into the pathophysiology of autoimmune 
diseases.
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